UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 664

Sortiert nach

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

European journal of cancer (1990), 2015-07, Vol.51 (11), p.1405-1414

2015

Volltextzugriff (PDF)

Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3296-3302

2003

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo

European journal of cancer (1990), 2012-07, Vol.48 (10), p.1434-1442

2012

Volltextzugriff (PDF)

Effect of plasma ion immersion implantation on physiochemical and biological properties of silk towards creating a versatile biomaterial platform

Materials today advances, 2022-03, Vol.13, p.100212, Article 100212

2022

Volltextzugriff (PDF)

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

European journal of cancer (1990), 2014-07, Vol.50 (11), p.1909-1915

2014

Volltextzugriff (PDF)

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3335-3342

2003

Volltextzugriff (PDF)

Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Journal of clinical oncology, 2005-01, Vol.23 (3), p.455-460

2005

Volltextzugriff (PDF)

Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancer

Current oncology (Toronto), 2014-02, Vol.21 (1), p.e41-e51

2014

Volltextzugriff (PDF)

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-11, Vol.16 (6), p.1106-1112

2016

Volltextzugriff (PDF)

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies

Biomaterials, 2004-04, Vol.25 (9), p.1505-1510

2004

Volltextzugriff (PDF)

What can conservation culturomics tell us about factors driving public interest in aquatic endangered species

Biological conservation, 2024-01, Vol.289, p.110397, Article 110397

2024

Volltextzugriff (PDF)

Prognostic score and nomogram to predict overall survival in locally advanced pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2015-06, Vol.15 (3), p.S107-S107

2015

Volltextzugriff (PDF)

Perfluoropyridine as a Scaffold for Semifluorinated Thiol‐ene Networks with Readily Tunable Thermal Properties

Macromolecular chemistry and physics, 2020-06, Vol.221 (12), p.n/a

2020

Volltextzugriff (PDF)

Air processed P3HT:PCBM photovoltaic cells: Morphology correlation to annealing, degradation, and recovery

Journal of polymer science. Part B, Polymer physics, 2014-12, Vol.52 (23), p.1511-1520

2014

Volltextzugriff (PDF)

Bowhead Whales, and Not Right Whales, Were the Primary Target of 16th-to 17th-Century Basque Whalers in the Western North Atlantic

Arctic, 2008-03, Vol.61 (1), p.61-75

2008

Volltextzugriff (PDF)

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

Annals of oncology, 2014-09, Vol.25 (9), p.1750-1755

2014

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

Annals of oncology, 2015-05, Vol.26 (5), p.921-927

2015

Volltextzugriff (PDF)

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4906-4911

2008

Volltextzugriff (PDF)

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer

Annals of oncology, 2017-02, Vol.28 (2), p.354-361

2017

Volltextzugriff (PDF)

Phase II Study of Troxacitabine (BCH-4556) in Patients With Advanced and/or Metastatic Renal Cell Carcinoma: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1524-1529

2003

Volltextzugriff (PDF)

Experimental and computational models of neurite extension at a choice point in response to controlled diffusive gradients

Journal of neural engineering, 2015-08, Vol.12 (4), p.046012-046012

2015

Volltextzugriff (PDF)

The SHIPEM REGISTRY: Shipping infarcts for primary angioplasty in Eastern Melbourne

Heart, lung & circulation, 2009, Vol.18, p.S237-S237

2009

Volltextzugriff (PDF)

Gender differences in percutaneous coronary intervention (PCI) in the drug eluting stent (DES) era: Melbourne Interventional Group (MIG) Registry

Heart, lung & circulation, 2009, Vol.18, p.S213-S213

2009

Volltextzugriff (PDF)

Polycyanurates via Molecular Dynamics: In Situ Crosslinking from Di(Cyanate Ester) Resins and Model Validation through Comparison to Experiment

Macromolecules, 2021-07, Vol.54 (13), p.6275-6284

2021

Volltextzugriff (PDF)

1 – 25 von 664

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(578)
Mit Volltextzugriff
(616)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(660)
Japanisch
(64)
Spanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(419)
Life Sciences & Biomedicine
(297)
Humans
(164)
Female
(124)
Male
(119)
Biological And Medical Sciences
(117)
Animals
(108)
Physical Sciences
(89)
Technology
(76)
Adult
(70)
Fundamental And Applied Biological Sciences. Psychology
(63)
Middle Aged
(60)
Medical Sciences
(58)
Physics
(57)
Aged
(52)
Engineering
(35)
Exact Sciences And Technology
(35)
Oncology
(29)
Chemistry
(27)
Environmental Sciences & Ecology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo

Effect of plasma ion immersion implantation on physiochemical and biological properties of silk towards creating a versatile biomaterial platform

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancer

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies

What can conservation culturomics tell us about factors driving public interest in aquatic endangered species

Prognostic score and nomogram to predict overall survival in locally advanced pancreatic cancer

Perfluoropyridine as a Scaffold for Semifluorinated Thiol‐ene Networks with Readily Tunable Thermal Properties

Air processed P3HT:PCBM photovoltaic cells: Morphology correlation to annealing, degradation, and recovery

Bowhead Whales, and Not Right Whales, Were the Primary Target of 16th-to 17th-Century Basque Whalers in the Western North Atlantic

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer

Phase II Study of Troxacitabine (BCH-4556) in Patients With Advanced and/or Metastatic Renal Cell Carcinoma: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Experimental and computational models of neurite extension at a choice point in response to controlled diffusive gradients

The SHIPEM REGISTRY: Shipping infarcts for primary angioplasty in Eastern Melbourne

Gender differences in percutaneous coronary intervention (PCI) in the drug eluting stent (DES) era: Melbourne Interventional Group (MIG) Registry

Polycyanurates via Molecular Dynamics: In Situ Crosslinking from Di(Cyanate Ester) Resins and Model Validation through Comparison to Experiment

Suchergebnisse filtern